Perrigo Company PLC (PRGO)
Current ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 2,832,900 | 2,719,900 | 3,859,900 | 3,133,500 | 2,730,600 |
Total current liabilities | US$ in thousands | 1,586,300 | 1,113,600 | 1,587,900 | 1,382,000 | 1,335,800 |
Current ratio | 1.79 | 2.44 | 2.43 | 2.27 | 2.04 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $2,832,900K ÷ $1,586,300K
= 1.79
The current ratio of Perrigo Company plc has shown fluctuations over the past five years. In 2023, the current ratio stands at 1.79, a decrease from the previous year's ratio of 2.44. This implies the company may face difficulties in meeting its short-term obligations with its current assets. However, compared to 2019's ratio of 2.06, there has been an improvement in liquidity. Further analysis is required to understand the factors causing this fluctuation and to assess the company's overall liquidity position in more detail.
Peer comparison
Dec 31, 2023
Company name
Symbol
Current ratio
Perrigo Company PLC
PRGO
1.79
Abbott Laboratories
ABT
1.64
AbbVie Inc
ABBV
0.87
Alkermes Plc
ALKS
2.86
Amphastar P
AMPH
2.17
ANI Pharmaceuticals Inc
ANIP
3.57
Arcus Biosciences Inc
RCUS
4.52
Biomarin Pharmaceutical Inc
BMRN
2.51
Bristol-Myers Squibb Company
BMY
1.43
Catalent Inc
CTLT
2.52
Catalyst Pharmaceuticals Inc
CPRX
2.88